Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelaic acid gel for acne and post-inflammatory erythema/pigmentation
ChiCTR2300076959Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Azelaic acid in acne vulgaris (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Lesion improvement rate for acne lesions, papules, pustules, post-inflammatory erythema, and post-inflammatory pigmentation, Acne investigator's global assessment and 4 more. Started Oct 2022; status: completed.
02
Drugs
Azelaic acid
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ChiCTR2300076959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076959.